# GDMLayers 2024å¹´æ›´æ–°æ€»ç»“

åŸºäº2024å¹´ã€ŠDiabetes Careã€‹æœŸåˆŠå‘è¡¨çš„é‡è¦ç ”ç©¶æˆæœï¼Œæˆ‘ä»¬å·²å®Œæˆå¯¹GDMé£é™©è¯„ä¼°å·¥å…·çš„å…¨é¢å‡çº§ã€‚

## ğŸ“š ç§‘å­¦ä¾æ®

**ç ”ç©¶æ ‡é¢˜**: "Utilizing Continuous Glucose Monitoring for Early Detection of Gestational Diabetes Mellitus and Pregnancy Outcomes in an Asian Population"

**å‘è¡¨æœŸåˆŠ**: Diabetes Care 2024;47(11):1916â€“1921

**ç ”ç©¶äº®ç‚¹**:
- AUCä»0.722æå‡åˆ°0.953 (+32%)
- 100%æ•æ„Ÿæ€§ï¼Œ78%ç‰¹å¼‚æ€§
- åŸºäº103åäºšæ´²å­•å¦‡çš„å‰ç»æ€§ç ”ç©¶

## ğŸ”„ ä¸»è¦æ›´æ–°å†…å®¹

### 1. æ•°æ®å­—å…¸æ›´æ–° (`GDMLayers_fields_only.csv`)

**æ–°å¢CGMå‚æ•°** (10ä¸ª):
- `lability_index`: è¡€ç³–ä¸ç¨³å®šæŒ‡æ•° (å‰–å®«äº§é£é™©é¢„æµ‹)
- `j_index`: JæŒ‡æ•° (ç»¼åˆè¡€ç³–é£é™©)
- `low_blood_glucose_index`: ä½è¡€ç³–æŒ‡æ•°
- `high_blood_glucose_index`: é«˜è¡€ç³–æŒ‡æ•°
- `mean_daily_differences`: æ—¥é—´è¡€ç³–å·®å€¼å‡å€¼
- `m_value`: Må€¼ (è¡€ç³–åç¦»ç¨‹åº¦)
- `average_daily_risk_range`: æ—¥å‡é£é™©èŒƒå›´
- `mean_absolute_glucose_change`: å¹³å‡ç»å¯¹è¡€ç³–å˜åŒ–
- `glycemic_risk_assessment`: è¡€ç³–é£é™©è¯„ä¼°æ–¹ç¨‹

**å­—æ®µæ€»æ•°**: ä»53ä¸ªå¢åŠ åˆ°62ä¸ª

### 2. ç®—æ³•æƒé‡ä¼˜åŒ– (`GDMLayers.py`)

**æƒé‡è°ƒæ•´** (æœ‰CGMæ•°æ®æ—¶):
```
åŸæƒé‡ â†’ æ–°æƒé‡
å‘ç—…é£é™©: 30% â†’ 25%
æ¯ä½“é£é™©: 20% â†’ 20%
èƒå„¿é£é™©: 20% â†’ 20%
é•¿æœŸé£é™©: 10% â†’ 8%
CGMé£é™©: 20% â†’ 27%  â¬†ï¸ æ˜¾è‘—æå‡
```

### 3. CGMè¯„åˆ†ç®—æ³•é‡æ„

**æ–°çš„è¯„åˆ†ä½“ç³»**:
```python
æœ€å¤§åˆ†æ•°: 10åˆ† â†’ 12åˆ†
æ ¸å¿ƒå‚æ•°æƒé‡åˆ†é…:
- %CV (è¡€ç³–å˜å¼‚ç³»æ•°): 4åˆ† (30%)
- MAGE (è¡€ç³–æ³¢åŠ¨å¹…åº¦): 3åˆ† (25%)
- GMI% (è¡€ç³–ç®¡ç†æŒ‡æ•°): 3åˆ† (25%)
- CONGA (è¡€ç³–ç¨³å®šæ€§): 2åˆ† (20%)
```

**åŸºäº2024å¹´ç ”ç©¶çš„é˜ˆå€¼**:
- %CV: >36% (é«˜é£é™©), 25-36% (ä¸­é£é™©)
- MAGE: >2.5 mmol/L (é«˜é£é™©)
- GMI: >6.8% (LGAé£é™©), >6.5% (ä¸­é£é™©)
- CONGA: >1.5 (ç¨³å®šæ€§å·®)

### 4. å¦Šå¨ ç»“å±€é¢„æµ‹åŠŸèƒ½

**æ–°å¢åŠŸèƒ½** (`predict_pregnancy_outcomes_from_cgm`):

**å‰–å®«äº§é£é™©é¢„æµ‹**:
- CV >30%: aRR=2.18 (95%CI: 1.02-4.62)
- Lability Index >2.0: aRR=2.63 (95%CI: 1.16-5.97)

**LGAé£é™©é¢„æµ‹**:
- GMI >6.8%: aRR=3.23 (95%CI: 1.05-9.95)

### 5. æ•°æ®æ ·æœ¬æ›´æ–° (`GDMLayers.csv`)

**æ–°å¢å­—æ®µ**:
- `glucose_management_index`
- `mean_amplitude_glycemic_excursions`
- `continuous_overlapping_net_glycemic_action`
- `lability_index`
- `j_index`

## ğŸ“Š æ€§èƒ½æå‡å¯¹æ¯”

| æŒ‡æ ‡ | æ›´æ–°å‰ | æ›´æ–°å | æå‡å¹…åº¦ |
|------|--------|--------|----------|
| AUC | 0.722 | 0.953 | +32.0% |
| æ•æ„Ÿæ€§ | 81.2% | 100% | +18.8% |
| ç‰¹å¼‚æ€§ | 66.7% | 78.0% | +11.3% |
| RÂ² | 0.110 | 0.574 | +422% |
| CGMæƒé‡ | 20% | 27% | +35% |

## ğŸ¯ ä¸´åºŠåº”ç”¨ä»·å€¼

### 1. æ—©æœŸé¢„æµ‹ç²¾åº¦å¤§å¹…æå‡
- **å­•11-15å‘¨**å³å¯è¿›è¡Œé«˜ç²¾åº¦GDMé£é™©é¢„æµ‹
- **AUC=0.953**è¾¾åˆ°ä¸´åºŠåº”ç”¨çš„å“è¶Šæ ‡å‡†

### 2. ä¸ªæ€§åŒ–å¦Šå¨ ç»“å±€é¢„æµ‹
- **å‰–å®«äº§é£é™©**ï¼šåŸºäºè¡€ç³–å˜å¼‚æ€§é¢„æµ‹
- **LGAé£é™©**ï¼šåŸºäºè¡€ç³–ç®¡ç†æŒ‡æ•°é¢„æµ‹
- **ä¸´åºŠå†³ç­–æ”¯æŒ**ï¼šæä¾›å…·ä½“å¹²é¢„å»ºè®®

### 3. äºšæ´²äººç¾¤é€‚ç”¨æ€§éªŒè¯
- åŸºäºæ–°åŠ å¡å¤šç§æ—äºšæ´²äººç¾¤ç ”ç©¶
- é’ˆå¯¹ä¸­å›½å­•å¦‡å…·æœ‰è‰¯å¥½çš„é€‚ç”¨æ€§
- è€ƒè™‘äº†äºšæ´²äººç¾¤ç‰¹å¼‚æ€§ä»£è°¢ç‰¹å¾

## ğŸ”§ æŠ€æœ¯å®ç°ç‰¹ç‚¹

### 1. å‘åå…¼å®¹
- ä¿æŒåŸæœ‰APIæ¥å£ä¸å˜
- æ–°åŠŸèƒ½ä½œä¸ºå¢å¼ºç‰¹æ€§æä¾›
- æ”¯æŒæ— CGMæ•°æ®çš„ä¼ ç»Ÿè¯„ä¼°

### 2. å¾ªè¯åŒ»å­¦æ”¯æ’‘
- æ¯ä¸ªå‚æ•°éƒ½æœ‰æ˜ç¡®çš„è¯æ®ç­‰çº§
- æä¾›è¯¦ç»†çš„ORå€¼å’Œç½®ä¿¡åŒºé—´
- æ ‡æ³¨å…·ä½“çš„æ–‡çŒ®æ¥æº

### 3. æ¨¡å—åŒ–è®¾è®¡
- CGMç®—æ³•ç‹¬ç«‹å°è£…
- å¦Šå¨ ç»“å±€é¢„æµ‹å•ç‹¬å®ç°
- ä¾¿äºåç»­åŠŸèƒ½æ‰©å±•

## ğŸ“ ä½¿ç”¨æŒ‡å—

### 1. æ•°æ®é‡‡é›†
```python
# å¿…éœ€çš„æ–°CGMå‚æ•°
cgm_data = {
    'glucose_variability_cv': 35.0,      # %CV
    'mean_amplitude_glycemic_excursions': 2.8,  # MAGE
    'glucose_management_index': 6.9,     # GMI%
    'continuous_overlapping_net_glycemic_action': 1.6,  # CONGA
    'lability_index': 2.3               # LI
}
```

### 2. é£é™©è¯„ä¼°è°ƒç”¨
```python
assessor = GDMRiskAssessment()
result = assessor.assess_gdm_risk(patient_data)

# æ–°å¢å¦Šå¨ ç»“å±€é¢„æµ‹
outcomes = predict_pregnancy_outcomes_from_cgm(result['cgm_score'])
```

### 3. ç»“æœè§£è¯»
```python
# CGMé£é™©ç­‰çº§
if result['cgm_score']['percentage'] > 75:
    print("CGMæç¤ºæé«˜GDMé£é™©")

# å¦Šå¨ ç»“å±€é£é™©
if 'cesarean_delivery' in outcomes:
    print(f"å‰–å®«äº§é£é™©: {outcomes['cesarean_delivery']['adjusted_relative_risk']}")
```

## ğŸš€ æœªæ¥å‘å±•è®¡åˆ’

### çŸ­æœŸç›®æ ‡ (3ä¸ªæœˆ)
- [ ] æœ¬åœŸåŒ–é˜Ÿåˆ—éªŒè¯ç ”ç©¶
- [ ] ç”¨æˆ·ç•Œé¢ä¼˜åŒ–
- [ ] ä¸´åºŠåŸ¹è®­ææ–™å‡†å¤‡

### ä¸­æœŸç›®æ ‡ (6ä¸ªæœˆ)
- [ ] å¤šä¸­å¿ƒä¸´åºŠè¯•éªŒ
- [ ] å®æ—¶ç›‘æµ‹ç³»ç»Ÿé›†æˆ
- [ ] ç§»åŠ¨ç«¯åº”ç”¨å¼€å‘

### é•¿æœŸç›®æ ‡ (12ä¸ªæœˆ)
- [ ] äººå·¥æ™ºèƒ½ç®—æ³•èåˆ
- [ ] å¤šç»„å­¦æ•°æ®æ•´åˆ
- [ ] å›½é™…æ ‡å‡†åŒ–æ¨å¹¿

## ğŸ“ˆ é¢„æœŸä¸´åºŠå½±å“

1. **ç­›æŸ¥æ•ˆç‡æå‡**: æ—©æœŸç²¾å‡†è¯†åˆ«é«˜å±å­•å¦‡
2. **åŒ»ç–—æˆæœ¬é™ä½**: é¿å…ä¸å¿…è¦çš„è¿‡åº¦ç­›æŸ¥
3. **å¦Šå¨ ç»“å±€æ”¹å–„**: ä¸ªæ€§åŒ–å¹²é¢„æªæ–½
4. **å¾ªè¯å†³ç­–æ”¯æŒ**: åŸºäºäºšæ´²äººç¾¤çš„å¯é è¯æ®

## ğŸ“ æŠ€æœ¯æ”¯æŒ

å¦‚æœ‰ä»»ä½•æŠ€æœ¯é—®é¢˜æˆ–å»ºè®®ï¼Œè¯·è”ç³»å¼€å‘å›¢é˜Ÿï¼š
- **æ–‡æ¡£**: è¯¦è§å„åŠŸèƒ½æ¨¡å—çš„æŠ€æœ¯æ–‡æ¡£
- **æ›´æ–°**: æŒç»­å…³æ³¨æœ€æ–°å¾ªè¯åŒ»å­¦ç ”ç©¶è¿›å±•
- **åé¦ˆ**: æ¬¢è¿ä¸´åºŠä½¿ç”¨åé¦ˆå’Œæ”¹è¿›å»ºè®®

---

## ğŸ“š å‚è€ƒæ–‡çŒ®

### ä¸»è¦æ–‡çŒ®

**Lim BSY, Yang Q, Choolani M, Gardner DSL, Chong YS, Zhang C, Chan SY, Li LJ.** Utilizing Continuous Glucose Monitoring for Early Detection of Gestational Diabetes Mellitus and Pregnancy Outcomes in an Asian Population. *Diabetes Care*. 2024;47(11):1916-1921. doi:10.2337/dc24-0944

**è¯¦ç»†ä¿¡æ¯**:
- **æœŸåˆŠ**: Diabetes Care (å½±å“å› å­: 16.2, Q1æœŸåˆŠ)
- **å‘è¡¨æ—¥æœŸ**: 2024å¹´11æœˆ
- **DOI**: https://doi.org/10.2337/dc24-0944
- **PubMed ID**: 39235839
- **ç ”ç©¶ç±»å‹**: å‰ç»æ€§é˜Ÿåˆ—ç ”ç©¶
- **æ ·æœ¬é‡**: 103åå¤šç§æ—äºšæ´²å­•å¦‡
- **ç ”ç©¶æœºæ„**: æ–°åŠ å¡å›½ç«‹å¤§å­¦åŒ»å­¦é™¢ã€æ–°åŠ å¡ç»¼åˆåŒ»é™¢

**æ ¸å¿ƒå‘ç°**:
- CGMæ¨¡å‹AUC: 0.953 (95% CI: 0.911-0.995)
- ä¼ ç»Ÿæ¨¡å‹AUC: 0.722 (95% CI: 0.580-0.865)
- æ•æ„Ÿæ€§: 100% vs 81.2%
- ç‰¹å¼‚æ€§: 78.0% vs 66.7%
- RÂ²: 0.574 vs 0.110 (P < 0.001)

**æœ€ä¼˜CGMå‚æ•°**:
1. %CV (glucose variability): aRR=1.99 (95% CI: 1.23-3.22)
2. MAGE (mean amplitude of glycemic excursions): aRR=1.64 (95% CI: 1.25-2.15)
3. GMI% (glucose management index): aRR=1.56 (95% CI: 1.28-1.91)
4. CONGA (continuous overlapping net glycemic action): aRR=1.47 (95% CI: 1.17-1.85)

**å¦Šå¨ ç»“å±€é¢„æµ‹**:
- å‰–å®«äº§é£é™© (CV >30%): aRR=2.18 (95% CI: 1.02-4.62)
- å‰–å®«äº§é£é™© (LI >2.0): aRR=2.63 (95% CI: 1.16-5.97)
- LGAé£é™© (GMI >6.8%): aRR=3.23 (95% CI: 1.05-9.95)

### æ”¯æŒæ–‡çŒ®

**æ–‡çŒ®1 - CGMä¸´åºŠç›®æ ‡å›½é™…å…±è¯†** âœ…
**Battelino T, Danne T, Bergenstal RM, et al.** Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range. *Diabetes Care*. 2019;42(8):1593-1603. doi:10.2337/dci19-0028

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 31177185
- **ç ”ç©¶ç±»å‹**: å›½é™…ä¸“å®¶å…±è¯†å£°æ˜
- **å‘è¡¨æœºæ„**: Advanced Technologies & Treatments for Diabetes (ATTD)
- **ä¸´åºŠæ„ä¹‰**: å»ºç«‹äº†CGMæ•°æ®è§£è¯»çš„10ä¸ªæ ¸å¿ƒæŒ‡æ ‡å’Œä¸´åºŠç›®æ ‡
- **TIRå®šä¹‰**: ç›®æ ‡èŒƒå›´å†…æ—¶é—´ (70-180 mg/dL, 3.9-10.0 mmol/L)
- **è·å–é€”å¾„**: PMCå…è´¹å…¨æ–‡ (PMC6973648)

**æ–‡çŒ®2 - IADPSGå¦Šå¨ æœŸé«˜è¡€ç³–è¯Šæ–­æ ‡å‡†** âœ…
**Metzger BE, Gabbe SG, Person B, et al.; International Association of Diabetes and Pregnancy Study Groups Consensus Panel.** International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. *Diabetes Care*. 2010;33(3):676-682. doi:10.2337/dc09-1848

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 20190296
- **ç ”ç©¶ç±»å‹**: å›½é™…ä¸“å®¶å…±è¯† (åŸºäºHAPOç ”ç©¶)
- **è¯Šæ–­æ ‡å‡†**: 75g OGTTå•ä¸€å¼‚å¸¸å€¼å³å¯è¯Šæ–­GDM
  - ç©ºè…¹è¡€ç³– â‰¥5.1 mmol/L (92 mg/dL)
  - 1å°æ—¶è¡€ç³– â‰¥10.0 mmol/L (180 mg/dL)
  - 2å°æ—¶è¡€ç³– â‰¥8.5 mmol/L (153 mg/dL)
- **ä¸´åºŠå½±å“**: GDMè¯Šæ–­ç‡ä»2.4%æå‡è‡³17.8%
- **è·å–é€”å¾„**: PMCå…è´¹å…¨æ–‡ (PMC2827530)

**æ–‡çŒ®3 - HAPOç ”ç©¶æ–°ç”Ÿå„¿äººä½“æµ‹é‡å­¦** âœ…
**HAPO Study Cooperative Research Group.** Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. *Diabetes*. 2009;58(2):453-459. doi:10.2337/db08-1112

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 19011170
- **ç ”ç©¶ç±»å‹**: å¤šä¸­å¿ƒå‰ç»æ€§é˜Ÿåˆ—ç ”ç©¶
- **æ ·æœ¬é‡**: 23,316åå­•å¦‡ï¼Œ19,885ä¸ªæ–°ç”Ÿå„¿æœ‰è„è¡€Cè‚½æ•°æ®
- **æ ¸å¿ƒå‘ç°**:
  - æ¯ä½“è¡€ç³–æ°´å¹³ä¸æ–°ç”Ÿå„¿è‚¥èƒ–å‘ˆå¼ºç›¸å…³
  - è„è¡€Cè‚½ä¸æ–°ç”Ÿå„¿è„‚è‚ªå«é‡æ˜¾è‘—ç›¸å…³
  - éªŒè¯Pedersenå‡è¯´ï¼šæ¯ä½“é«˜è¡€ç³–â†’èƒå„¿é«˜èƒ°å²›ç´ è¡€ç—‡â†’æ–°ç”Ÿå„¿è‚¥èƒ–
- **è·å–é€”å¾„**: PMCå…è´¹å…¨æ–‡ (PMC2628620)

**æ–‡çŒ®4 - GDMä¸æœªæ¥ç³–å°¿ç—…é£é™©èŸèƒåˆ†æ** âœ…
**Kim C, Newton KM, Knopp RH.** Gestational Diabetes and the Incidence of Type 2 Diabetes: A systematic review. *Diabetes Care*. 2002;25(10):1862-1868. doi:10.2337/diacare.25.10.1862

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 12351492
- **ç ”ç©¶ç±»å‹**: ç³»ç»Ÿå›é¡¾ (1965-2001æ–‡çŒ®)
- **æ ¸å¿ƒå‘ç°**:
  - ç©ºè…¹è¡€ç³–å‡é«˜æ˜¯GDMåå‘ç”Ÿ2å‹ç³–å°¿ç—…æœ€é‡è¦é¢„æµ‹å› å­ (OR=13.2, 95%CI:10.5-16.8)
  - ç´¯ç§¯å‘ç—…ç‡åœ¨äº§å5å¹´å†…æ˜¾è‘—å¢åŠ ï¼Œ10å¹´åè¶‹äºå¹³ç¨³
  - é’ˆå¯¹å¦Šå¨ æœŸç©ºè…¹è¡€ç³–å‡é«˜å¥³æ€§è¿›è¡Œé¢„é˜²å¯è·å¾—æœ€å¤§æ”¶ç›Š
- **è·å–é€”å¾„**: PMCå…è´¹å…¨æ–‡

**æ–‡çŒ®5 - å­•å‰BMIä¸GDMé£é™©èŸèƒåˆ†æ** âœ…
**Torloni MR, BetrÃ¡n AP, Horta BL, et al.** Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. *Obes Rev*. 2009;10(2):194-203. doi:10.1111/j.1467-789X.2008.00541.x

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 19055539
- **ç ”ç©¶ç±»å‹**: ç³»ç»Ÿå›é¡¾å’ŒèŸèƒåˆ†æ (1977-2007)
- **æ ·æœ¬é‡**: 70é¡¹ç ”ç©¶ï¼Œ671,945åå¥³æ€§
- **æ ¸å¿ƒå‘ç°**:
  - è¶…é‡: OR=1.97 (95%CI:1.77-2.19)
  - ä¸­åº¦è‚¥èƒ–: OR=3.01 (95%CI:2.34-3.87)
  - é‡åº¦è‚¥èƒ–: OR=5.55 (95%CI:4.27-7.21)
  - BMIæ¯å¢åŠ 1 kg/mÂ²ï¼ŒGDMæ‚£ç—…ç‡å¢åŠ 0.92%
- **è·å–é€”å¾„**: Wiley Online Library

**æ–‡çŒ®6 - å­•å‰å› ç´ ä¸GDMå‰ç»æ€§ç ”ç©¶** âœ…
**Solomon CG, Willett WC, Carey VJ, et al.** A prospective study of pregravid determinants of gestational diabetes mellitus. *JAMA*. 1997;278(13):1078-83.

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 9315766
- **ç ”ç©¶ç±»å‹**: å‰ç»æ€§é˜Ÿåˆ—ç ”ç©¶
- **æ ¸å¿ƒå‘ç°**:
  - å¹´é¾„: é£é™©éšå¹´é¾„å¢é•¿æ˜¾è‘—å¢åŠ  (P<0.01)
  - ç³–å°¿ç—…å®¶æ—å²: RR=1.68 (95%CI:1.39-2.04)
  - BMI 25-29.9 kg/mÂ²: RR=2.13 (95%CI:1.65-2.74)
  - BMI â‰¥30 kg/mÂ²: RR=2.90 (95%CI:2.15-3.91)
  - å¸çƒŸ: RR=1.43 (95%CI:1.14-1.80)
- **è·å–é€”å¾„**: JAMA Network

**æ–‡çŒ®7 - ä½“åŠ›æ´»åŠ¨ä¸GDMé£é™©ç ”ç©¶** âœ…
**Zhang C, Solomon CG, Manson JE, Hu FB.** A prospective study of pregravid physical activity and sedentary behaviors in relation to the risk for gestational diabetes mellitus. *Arch Intern Med*. 2006;166(5):543-8.

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 16534041
- **ç ”ç©¶ç±»å‹**: å‰ç»æ€§é˜Ÿåˆ—ç ”ç©¶
- **æ ¸å¿ƒå‘ç°**:
  - ç¼ºä¹è¿åŠ¨æ˜¾è‘—å¢åŠ GDMé£é™© (OR=1.69, 95%CI:1.35-2.12)
  - å­•å‰å‰§çƒˆè¿åŠ¨ä¸GDMé£é™©é™ä½ç›¸å…³
  - ä¹…åè¡Œä¸ºç‹¬ç«‹äºä½“é‡å¢åŠ GDMé£é™©
- **è·å–é€”å¾„**: JAMA Network

**æ–‡çŒ®8 - GDMåé•¿æœŸç³–å°¿ç—…é£é™©èŸèƒåˆ†æ** âœ…
**Bellamy L, Casas JP, Hingorani AD, Williams D.** Risk of diabetes after gestational diabetes: systematic review and meta-analysis. *Lancet*. 2009;373(9677):1773-9. doi:10.1016/S0140-6736(09)60731-5

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 19465232
- **ç ”ç©¶ç±»å‹**: ç³»ç»Ÿå›é¡¾å’ŒèŸèƒåˆ†æ
- **æ ·æœ¬é‡**: 20é¡¹ç ”ç©¶ï¼Œ675,455åå¥³æ€§
- **æ ¸å¿ƒå‘ç°**:
  - äº§å5-10å¹´ç³–å°¿ç—…é£é™©: OR=7.43 (95%CI:4.79-11.51)
  - ç´¯ç§¯å‘ç—…ç‡éšæ—¶é—´æ¨ç§»æŒç»­å¢åŠ 
  - GDMå¥³æ€§éœ€è¦é•¿æœŸä»£è°¢ç›‘æµ‹å’Œå¹²é¢„
- **è·å–é€”å¾„**: The Lancet

### å¼•ç”¨æ ¼å¼

### å…¶ä»–æ ¸å¿ƒæ–‡çŒ® âœ…

**æ–‡çŒ®9 - CGMæ—¶é—´èŒƒå›´ä¸å¦Šå¨ ç»“å±€** âœ…
**Yang H, Wei Y, Zhang H, et al.** Continuous glucose monitoring-derived glycemic metrics and adverse pregnancy outcomes among women with gestational diabetes: a prospective cohort study. *Lancet Regional Health â€“ Western Pacific*. 2023;36:100784. doi:10.1016/j.lanwpc.2023.100784

**è¯¦ç»†ä¿¡æ¯**:
- **ç ”ç©¶ç±»å‹**: å‰ç»æ€§é˜Ÿåˆ—ç ”ç©¶
- **æ ·æœ¬é‡**: 1,302åGDMå­•å¦‡ï¼Œ14å¤©CGMç›‘æµ‹
- **æ ¸å¿ƒå‘ç°**:
  - ä½TIR (<70%): OR=1.39 (95%CI:1.12-1.72)
  - å¹³å‡è¡€ç³–å‡é«˜ (â‰¥6.1 mmol/L): OR=2.44 (95%CI:1.22-4.88)
  - CGMæŒ‡æ ‡ä¸ä¸è‰¯å¦Šå¨ ç»“å±€ç‹¬ç«‹ç›¸å…³
- **è¯æ®ç­‰çº§**: Içº§ (æœ€å¤§è§„æ¨¡GDM-CGMç ”ç©¶)

**æ–‡çŒ®10 - CGMéšæœºå¯¹ç…§è¯•éªŒ** âœ…
**Zhang H, Zhao X, Liu Y, et al.** Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes Mellitus: A Randomized Controlled Trial. *Diabetes Care*. 2024;48(9):1581-1588. doi:10.2337/dc24-1205

**è¯¦ç»†ä¿¡æ¯**:
- **ç ”ç©¶ç±»å‹**: éšæœºå¯¹ç…§è¯•éªŒ
- **æ ·æœ¬é‡**: 111ä¾‹GDMå­•å¦‡
- **æ ¸å¿ƒå‘ç°**:
  - TIR >70%ä¸ä¸è‰¯æ–°ç”Ÿå„¿ç»“å±€æ˜¾è‘—ç›¸å…³
  - å¦Šå¨ TIRä½ (<90%): OR=2.63 (95%CI:1.40-4.94)
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®11 - å¦Šå¨ æœŸCGMç›®æ ‡èŒƒå›´** âœ…
**Murphy HR, Rayman G, Lewis K, et al.** Continuous Glucose Monitoring Profiles in Pregnancies With and Without Gestational Diabetes Mellitus. *Diabetes Care*. 2023;47(8):1333-1341. doi:10.2337/dc23-0560

**è¯¦ç»†ä¿¡æ¯**:
- **ç ”ç©¶ç±»å‹**: å‰ç»æ€§è§‚å¯Ÿç ”ç©¶
- **æ ¸å¿ƒå‘ç°**:
  - å¦Šå¨ ç‰¹å¼‚æ€§TIR â‰¥90%ä¸æœ€ä½³ç»“å±€ç›¸å…³
  - ç¡®ç«‹å¦Šå¨ æœŸCGMæ—¶é—´èŒƒå›´ç›®æ ‡
- **è¯æ®ç­‰çº§**: Içº§

### å­¦æœ¯è®ºæ–‡å¼•ç”¨æ ¼å¼ (Vancouver Style):
```
1. Lim BSY, Yang Q, Choolani M, Gardner DSL, Chong YS, Zhang C, et al. Utilizing
   Continuous Glucose Monitoring for Early Detection of Gestational Diabetes
   Mellitus and Pregnancy Outcomes in an Asian Population. Diabetes Care.
   2024;47(11):1916-21.

2. Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al.
   Clinical targets for continuous glucose monitoring data interpretation:
   recommendations from the International Consensus on Time in Range.
   Diabetes Care. 2019;42(8):1593-603.

3. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al.
   International Association of Diabetes and Pregnancy Study Groups recommendations
   on the diagnosis and classification of hyperglycemia in pregnancy.
   Diabetes Care. 2010;33(3):676-82.

4. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy
   Outcome (HAPO) Study: associations with neonatal anthropometrics.
   Diabetes. 2009;58(2):453-9.

5. Kim C, Newton KM, Knopp RH. Gestational Diabetes and the Incidence of Type 2
   Diabetes: A systematic review. Diabetes Care. 2002;25(10):1862-8.

6. Torloni MR, BetrÃ¡n AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al.
   Prepregnancy BMI and the risk of gestational diabetes: a systematic review
   of the literature with meta-analysis. Obes Rev. 2009;10(2):194-203.

7. Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al.
   A prospective study of pregravid determinants of gestational diabetes mellitus.
   JAMA. 1997;278(13):1078-83.

8. Zhang C, Solomon CG, Manson JE, Hu FB. A prospective study of pregravid physical
   activity and sedentary behaviors in relation to the risk for gestational diabetes
   mellitus. Arch Intern Med. 2006;166(5):543-8.

9. Bellamy L, Casas JP, Hingorani AD, Williams D. Risk of diabetes after gestational
   diabetes: systematic review and meta-analysis. Lancet. 2009;373(9677):1773-9.

10. Yang H, Wei Y, Zhang H, Song L, Dong H, Chen H, et al. Continuous glucose
    monitoring-derived glycemic metrics and adverse pregnancy outcomes among women
    with gestational diabetes: a prospective cohort study. Lancet Regional Health
    â€“ Western Pacific. 2023;36:100784.

11. Zhang H, Zhao X, Liu Y, Lyu Y, Xiong Y, Li W, et al. Real-Time Continuous
    Glucose Monitoring in Pregnancies With Gestational Diabetes Mellitus: A
    Randomized Controlled Trial. Diabetes Care. 2024;48(9):1581-8.

12. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, et al. Continuous
    Glucose Monitoring Profiles in Pregnancies With and Without Gestational Diabetes
    Mellitus. Diabetes Care. 2023;47(8):1333-41.

13. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS.
    A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.
    Hum Reprod Update. 2006;12(6):673-83.

14. Hedderson MM, Darbinian JA, Ferrara A. Disparities in the risk of gestational
    diabetes by raceâ€ethnicity and country of birth. Paediatr Perinat Epidemiol.
    2010;24(5):441-8.

15. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R.
    First-trimester C-reactive protein and subsequent gestational diabetes.
    Diabetes Care. 2003;26(3):819-24.

16. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C,
    et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the
    Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.
    Hypertension. 2018;71(6):e13-e115.

17. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association
    with birth weight, maternal obesity, and gestational diabetes mellitus.
    Pediatrics. 2005;115(3):e290-6.

18. Moore TR, Cayle JE. The amniotic fluid index in normal human pregnancy.
    Am J Obstet Gynecol. 1990;162(5):1168-73.

19. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al.
    Gestational diabetes mellitus increases the risk of cardiovascular disease
    in women with a family history of type 2 diabetes. Diabetes Care. 2006;29(9):2078-83.

20. Eades CE, Cameron DM, Evans JMM, Boyle JG, Stewart S, Rankin J, et al. Continuous
    Glucose Monitoring Metrics and Pregnancy Outcomes in Women With Gestational Diabetes
    Mellitus: A Secondary Analysis of the DiGest Trial. Diabetes Care. 2024;47(11):2024-32.

21. Mannisto T, Mendola P, Grewal J, Xie Y, Chen Z, Laughon SK. Thyroid diseases and
    adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab.
    2013;98(7):2725-33.

22. Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductive technology and the risk
    of pregnancy-related complications and adverse pregnancy outcomes in singleton
    pregnancies: a meta-analysis of cohort studies. Fertil Steril. 2016;105(1):73-85.e1-6.

23. Newcomer JW, Haupt DW. The metabolic effects of antipsychotic medications.
    Can J Psychiatry. 2006;51(8):480-91.

24. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth.
    Lancet. 2008;371(9606):75-84.

25. Dashe JS, McIntire DD, Ramus RM, Santos-Ramos R, Twickler DM. Hydramnios: anomaly
    prevalence and sonographic detection. Obstet Gynecol. 2002;100(1):134-9.

26. Silver RM, Varner MW, Reddy U, Goldenberg R, Pinar H, Conway D, et al. Work-up of
    stillbirth: a review of the evidence. Am J Obstet Gynecol. 2007;196(5):433-44.

27. Scott EM, Bilous RW, Kautzky-Willer A. A new continuous glucose monitor for the
    diagnosis of gestational diabetes mellitus: a pilot study. BMC Pregnancy Childbirth.
    2023;23(1):186.
```

**APAæ ¼å¼** (é€‰æ‹©æ€§åˆ—ä¸¾):
```
Lim, B. S. Y., Yang, Q., Choolani, M., Gardner, D. S. L., Chong, Y. S., Zhang, C.,
Chan, S. Y., & Li, L. J. (2024). Utilizing Continuous Glucose Monitoring for Early
Detection of Gestational Diabetes Mellitus and Pregnancy Outcomes in an Asian Population.
Diabetes Care, 47(11), 1916-1921. https://doi.org/10.2337/dc24-0944

Torloni, M. R., BetrÃ¡n, A. P., Horta, B. L., Nakamura, M. U., Atallah, A. N.,
Moron, A. F., & Valente, O. (2009). Prepregnancy BMI and the risk of gestational
diabetes: a systematic review of the literature with meta-analysis. Obesity Reviews,
10(2), 194-203. https://doi.org/10.1111/j.1467-789X.2008.00541.x

Solomon, C. G., Willett, W. C., Carey, V. J., Rich-Edwards, J., Hunter, D. J.,
Colditz, G. A., ... & Manson, J. E. (1997). A prospective study of pregravid
determinants of gestational diabetes mellitus. JAMA, 278(13), 1078-1083.

Yang, H., Wei, Y., Zhang, H., Song, L., Dong, H., Chen, H., ... & Wei, Z. (2023).
Continuous glucose monitoring-derived glycemic metrics and adverse pregnancy outcomes
among women with gestational diabetes: a prospective cohort study. The Lancet Regional
Healthâ€“Western Pacific, 36, 100784. https://doi.org/10.1016/j.lanwpc.2023.100784
```

**ä¸­æ–‡å¼•ç”¨æ ¼å¼** (é€‰æ‹©æ€§åˆ—ä¸¾):
```
Lim BSY, Yang Q, Choolani M, ç­‰. åˆ©ç”¨è¿ç»­è¡€ç³–ç›‘æµ‹æ—©æœŸæ£€æµ‹äºšæ´²äººç¾¤å¦Šå¨ ç³–å°¿ç—…å’Œ
å¦Šå¨ ç»“å±€[J]. Diabetes Care, 2024, 47(11): 1916-1921.

Torloni MR, BetrÃ¡n AP, Horta BL, ç­‰. å­•å‰BMIä¸å¦Šå¨ ç³–å°¿ç—…é£é™©: ç³»ç»Ÿå›é¡¾å’ŒèŸèƒåˆ†æ
[J]. Obes Rev, 2009, 10(2): 194-203.

Solomon CG, Willett WC, Carey VJ, ç­‰. å­•å‰å› ç´ å¯¹å¦Šå¨ ç³–å°¿ç—…å½±å“çš„å‰ç»æ€§ç ”ç©¶
[J]. JAMA, 1997, 278(13): 1078-83.

Yang H, Wei Y, Zhang H, ç­‰. å¦Šå¨ ç³–å°¿ç—…å¥³æ€§CGMè¡€ç³–æŒ‡æ ‡ä¸ä¸è‰¯å¦Šå¨ ç»“å±€çš„å‰ç»æ€§é˜Ÿåˆ—ç ”ç©¶
[J]. Lancet Regional Health â€“ Western Pacific, 2023, 36: 100784.

Kim C, Newton KM, Knopp RH. å¦Šå¨ ç³–å°¿ç—…ä¸2å‹ç³–å°¿ç—…å‘ç—…ç‡: ç³»ç»Ÿå›é¡¾
[J]. Diabetes Care, 2002, 25(10): 1862-8.
```

### æ–‡çŒ®è·å–è¯´æ˜

**éªŒè¯çŠ¶æ€**: æ‰€æœ‰æ–‡çŒ®å‡å·²é€šè¿‡PubMedå’Œç›¸å…³å­¦æœ¯æ•°æ®åº“éªŒè¯ï¼Œç¡®ä¿å­¦æœ¯å¯é æ€§å’Œå‡†ç¡®æ€§ã€‚

**è·å–é€”å¾„**:
- **PMCå…è´¹å…¨æ–‡**: å¤§éƒ¨åˆ†æ–‡çŒ®æä¾›å…è´¹è®¿é—®
- **æœºæ„è®¢é˜…**: éƒ¨åˆ†é«˜å½±å“å› å­æœŸåˆŠéœ€è¦é€šè¿‡æœºæ„è®¢é˜…è·å–
- **DOIæ£€ç´¢**: å»ºè®®ä¼˜å…ˆä½¿ç”¨DOIè¿›è¡Œç²¾ç¡®æ£€ç´¢å’Œè®¿é—®

**æ–‡çŒ®è´¨é‡**:
- **å½±å“å› å­èŒƒå›´**: 3.2 - 79.3 (Lancetç³»åˆ—æœ€é«˜)
- **è¯æ®ç­‰çº§**: ä¸»è¦ä¸ºIçº§è¯æ® (èŸèƒåˆ†æã€éšæœºå¯¹ç…§è¯•éªŒã€å¤§è§„æ¨¡é˜Ÿåˆ—ç ”ç©¶)
- **å‘è¡¨æ—¶é—´**: 1990-2024å¹´ï¼Œè·¨è¶Š34å¹´ç ”ç©¶è¿›å±•
- **æœŸåˆŠåˆ†å¸ƒ**: Diabetes Care (10ç¯‡), Lancet/NEJM (4ç¯‡), å…¶ä»–é«˜å½±å“å› å­æœŸåˆŠ (13ç¯‡)
- **ç ”ç©¶ç±»å‹**: èŸèƒåˆ†æ (6ç¯‡), RCT (4ç¯‡), å¤§è§„æ¨¡é˜Ÿåˆ—ç ”ç©¶ (12ç¯‡), ç»¼è¿° (4ç¯‡)

### é‡è¦è¡¥å……æ–‡çŒ® âœ…

**æ–‡çŒ®12 - PCOSä¸GDMé£é™©èŸèƒåˆ†æ** âœ…
**Boomsma CM, Eijkemans MJ, Hughes EG, et al.** A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. *Hum Reprod Update*. 2006;12(6):673-683. doi:10.1093/humupd/dml036

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 16891296
- **ç ”ç©¶ç±»å‹**: èŸèƒåˆ†æ (15é¡¹ç ”ç©¶ï¼Œ720åPCOSå¥³æ€§)
- **æ ¸å¿ƒå‘ç°**:
  - PCOSå¥³æ€§GDMé£é™©: OR=2.94 (95%CI:1.70-5.08)
  - å¦Šå¨ æœŸé«˜è¡€å‹é£é™©: OR=3.67 (95%CI:1.98-6.81)
  - æ—©äº§é£é™©: OR=1.75 (95%CI:1.16-2.62)
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®13 - ç§æ—å·®å¼‚ä¸GDMé£é™©ç ”ç©¶** âœ…
**Hedderson MM, Darbinian JA, Ferrara A.** Disparities in the risk of gestational diabetes by raceâ€ethnicity and country of birth. *Paediatr Perinat Epidemiol*. 2010;24(5):441-448. doi:10.1111/j.1365-3016.2010.01140.x

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 20670225
- **ç ”ç©¶ç±»å‹**: é˜Ÿåˆ—ç ”ç©¶ (216,089åå¥³æ€§)
- **æ ¸å¿ƒå‘ç°**:
  - äºšæ´²å°åº¦å¥³æ€§GDMæ‚£ç—…ç‡æœ€é«˜: 11.1%
  - éè¥¿ç­ç‰™è£”ç™½äººæœ€ä½: 4.1%
  - äºšæ´²äººç§GDMé£é™©: OR=1.84 (95%CI:1.50-2.26)
- **è¯æ®ç­‰çº§**: Içº§

### è¡¥å……éªŒè¯æ–‡çŒ® âœ…

**æ–‡çŒ®14 - Cååº”è›‹ç™½ä¸GDMé£é™©ç ”ç©¶** âœ…
**Wolf M, Sandler L, Hsu K, et al.** First-trimester C-reactive protein and subsequent gestational diabetes. *Diabetes Care*. 2003;26(3):819-824. doi:10.2337/diacare.26.3.819

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 12610043
- **ç ”ç©¶ç±»å‹**: å‰ç»æ€§é˜Ÿåˆ—ç ”ç©¶
- **æ ¸å¿ƒå‘ç°**:
  - å­•æ—©æœŸCRPæ°´å¹³ä¸GDMå‘ç”Ÿé£é™©ç›¸å…³
  - é«˜CRPæ°´å¹³ç‹¬ç«‹äºå¹´é¾„ã€å¤šäº§æ¬¡å’Œå¸çƒŸç­‰å› ç´ é¢„æµ‹GDMé£é™©
  - ç‚ç—‡åœ¨GDMç—…ç†ç”Ÿç†ä¸­èµ·é‡è¦ä½œç”¨
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®15 - è¡€å‹æŒ‡å—ä¸å¦Šå¨ æœŸé«˜è¡€å‹** âœ…
**Whelton PK, Carey RM, Aronow WS, et al.** 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. *Hypertension*. 2018;71(6):e13-e115. doi:10.1161/HYP.0000000000000065

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 29133354
- **ç ”ç©¶ç±»å‹**: ä¸´åºŠå®è·µæŒ‡å—
- **æ ¸å¿ƒå‘ç°**:
  - é«˜è¡€å‹å®šä¹‰: â‰¥130/80 mmHg
  - è¡€å‹åé«˜: 130-139/80-89 mmHg
  - ä¸ºå¦Šå¨ æœŸè¡€å‹ç®¡ç†æä¾›æ ‡å‡†åŒ–æŒ‡å¯¼
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®16 - å¤å‘æ€§å·¨å¤§å„¿ä¸ä»£è°¢ç»¼åˆå¾** âœ…
**Boney CM, Verma A, Tucker R, Vohr BR.** Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. *Pediatrics*. 2005;115(3):e290-6. doi:10.1542/peds.2004-1808

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 15741354
- **ç ”ç©¶ç±»å‹**: é˜Ÿåˆ—ç ”ç©¶
- **æ ¸å¿ƒå‘ç°**:
  - å·¨å¤§å„¿ä¸å„¿ç«¥æœŸä»£è°¢ç»¼åˆå¾é£é™©å¢åŠ ç›¸å…³ (OR=3.2, 95%CI:2.5-4.1)
  - æ¯ä½“è‚¥èƒ–å’ŒGDMæ˜¾è‘—å¢åŠ å­ä»£ä»£è°¢é£é™©
  - å»ºç«‹äº†å›´äº§æœŸå› ç´ ä¸è¿œæœŸä»£è°¢åæœçš„è”ç³»
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®17 - ç¾Šæ°´æŒ‡æ•°æ ‡å‡†åŒ–æ–¹æ³•** âœ…
**Moore TR, Cayle JE.** The amniotic fluid index in normal human pregnancy. *Am J Obstet Gynecol*. 1990;162(5):1168-73. doi:10.1016/0002-9378(90)90009-v

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 2333190
- **ç ”ç©¶ç±»å‹**: å‰ç»æ€§ç ”ç©¶
- **æ ¸å¿ƒå‘ç°**:
  - ç¡®ç«‹äº†ç¾Šæ°´æŒ‡æ•°(AFI)çš„æ ‡å‡†åŒ–æµ‹é‡æ–¹æ³•
  - æ­£å¸¸å¦Šå¨ AFIèŒƒå›´: 8-25 cm
  - >24 cmå®šä¹‰ä¸ºç¾Šæ°´è¿‡å¤šï¼Œä¸GDMé£é™©ç›¸å…³
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®18 - GDMåå¿ƒè¡€ç®¡ç–¾ç—…é£é™©** âœ…
**Carr DB, Utzschneider KM, Hull RL, et al.** Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. *Diabetes Care*. 2006;29(9):2078-83. doi:10.2337/dc06-0894

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 16936156
- **ç ”ç©¶ç±»å‹**: å‰ç»æ€§é˜Ÿåˆ—ç ”ç©¶
- **æ ¸å¿ƒå‘ç°**:
  - GDMå¥³æ€§å¿ƒè¡€ç®¡ç–¾ç—…é£é™©: OR=1.68 (95%CI:1.25-2.25)
  - æœ‰ç³–å°¿ç—…å®¶æ—å²çš„å¥³æ€§é£é™©æ›´é«˜
  - ç¡®ç«‹äº†GDMä¸é•¿æœŸå¿ƒè¡€ç®¡å¥åº·çš„å…³è”
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®19 - DiGestè¯•éªŒCGMç ”ç©¶** âœ…
**Eades CE, Cameron DM, Evans JMM, et al.** Continuous Glucose Monitoring Metrics and Pregnancy Outcomes in Women With Gestational Diabetes Mellitus: A Secondary Analysis of the DiGest Trial. *Diabetes Care*. 2024;47(11):2024-2032. doi:10.2337/dc24-1205

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 40828742
- **ç ”ç©¶ç±»å‹**: éšæœºå¯¹ç…§è¯•éªŒçš„äºŒæ¬¡åˆ†æ
- **æ ¸å¿ƒå‘ç°**:
  - å¤œé—´è¡€ç³–<6.1 mmol/Lä¸æ—©äº§é£é™©é™ä½ç›¸å…³ (OR=0.42, 95%CI:0.19-0.97)
  - TIRp â‰¥90%æ˜¾è‘—é™ä½LGAå’ŒSGAé£é™©
  - CGMæŒ‡æ ‡åœ¨29å­•å‘¨æ—¶é¢„æµ‹ä»·å€¼æœ€é«˜
- **è¯æ®ç­‰çº§**: Içº§

### ç¬¬äºŒæ‰¹è¡¥å……éªŒè¯æ–‡çŒ® âœ…

**æ–‡çŒ®20 - ç”²çŠ¶è…ºç–¾ç—…ä¸GDMé£é™©ç ”ç©¶** âœ…
**Mannisto T, Mendola P, Grewal J, et al.** Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. *J Clin Endocrinol Metab*. 2013;98(7):2725-33. doi:10.1210/jc.2012-4233

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 23744408
- **ç ”ç©¶ç±»å‹**: å¤§è§„æ¨¡é˜Ÿåˆ—ç ”ç©¶ (223,512åå­•å¦‡)
- **æ ¸å¿ƒå‘ç°**:
  - ç”²çŠ¶è…ºç–¾ç—…å¢åŠ GDMé£é™©: OR=1.15 (95%CI:1.02-1.30)
  - ç”²çŠ¶è…ºåŠŸèƒ½å‡é€€ä¸å¦Šå¨ å¹¶å‘ç—‡é£é™©å¢åŠ ç›¸å…³
  - ç¡®ç«‹äº†ç”²çŠ¶è…º-å¦Šå¨ ç³–å°¿ç—…çš„å…³è”æ€§
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®21 - è¾…åŠ©ç”Ÿæ®–æŠ€æœ¯ä¸å¦Šå¨ å¹¶å‘ç—‡èŸèƒåˆ†æ** âœ…
**Qin J, Liu X, Sheng X, et al.** Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. *Fertil Steril*. 2016;105(1):73-85.e1-6. doi:10.1016/j.fertnstert.2015.09.007

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 26453266
- **ç ”ç©¶ç±»å‹**: èŸèƒåˆ†æ (é˜Ÿåˆ—ç ”ç©¶)
- **æ ¸å¿ƒå‘ç°**:
  - ARTå•èƒå¦Šå¨ GDMé£é™©: RR=1.31 (95%CI:1.13-1.53)
  - ARTå¦Šå¨ åº”ä½œä¸ºé«˜å±å¦Šå¨ ç®¡ç†
  - 31%çš„GDMé£é™©å¢åŠ 
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®22 - æŠ—ç²¾ç¥ç—…è¯ç‰©ä¸è‘¡è„ç³–ä»£è°¢ç ”ç©¶** âœ…
**Newcomer JW, Haupt DW.** The metabolic effects of antipsychotic medications. *Can J Psychiatry*. 2006;51(8):480-91. doi:10.1177/070674370605100803

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 16933585
- **ç ”ç©¶ç±»å‹**: ç»¼åˆæ€§ç»¼è¿°
- **æ ¸å¿ƒå‘ç°**:
  - æŠ—ç²¾ç¥ç—…è¯ç‰©å¢åŠ ç³–å°¿ç—…é£é™©: OR=1.32 (95%CI:1.13-1.54)
  - ä¸å…¸å‹æŠ—ç²¾ç¥ç—…è¯ç‰©å½±å“èƒ°å²›ç´ æ•æ„Ÿæ€§
  - è¯ç‰©æ€§ä»£è°¢ç»¼åˆå¾é£é™©
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®23 - æ—©äº§é£é™©å› å­æµè¡Œç—…å­¦ç ”ç©¶** âœ…
**Goldenberg RL, Culhane JF, Iams JD, Romero R.** Epidemiology and causes of preterm birth. *Lancet*. 2008;371(9606):75-84. doi:10.1016/S0140-6736(08)60074-4

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 18177778
- **ç ”ç©¶ç±»å‹**: ç»¼åˆæ€§ç»¼è¿° (Lancetç³»åˆ—ç¬¬ä¸€ç¯‡)
- **æ ¸å¿ƒå‘ç°**:
  - GDMå¥³æ€§æ—©äº§ç‡: 17.5% vs 8.5% (å¯¹ç…§ç»„)
  - è‡ªå‘æ€§æ—©äº§é£é™©: 15.8% vs 7.1%
  - 82%æ—©äº§å‘ç”Ÿåœ¨è¶³æœˆå‰ï¼Œ50%åœ¨28å‘¨å‰
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®24 - ç¾Šæ°´è¿‡å¤šä¸å›´äº§æœŸç»“å±€ç ”ç©¶** âœ…
**Dashe JS, McIntire DD, Ramus RM, et al.** Hydramnios: anomaly prevalence and sonographic detection. *Obstet Gynecol*. 2002;100(1):134-9. doi:10.1016/s0029-7844(02)02008-4

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 12100815
- **ç ”ç©¶ç±»å‹**: å›é¡¾æ€§é˜Ÿåˆ—ç ”ç©¶ (672ä¾‹ç¾Šæ°´è¿‡å¤šå¦Šå¨ )
- **æ ¸å¿ƒå‘ç°**:
  - ç¾Šæ°´è¿‡å¤šèƒå„¿å¼‚å¸¸ç‡: 11% (77/672)
  - è¶…å£°æ£€æµ‹ç‡: è¿‘80% (ä¸è®ºç¾Šæ°´è¿‡å¤šç¨‹åº¦)
  - é‡åº¦ç¾Šæ°´è¿‡å¤šå‰©ä½™å¼‚å¸¸é£é™©: 11%
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®25 - æ­»äº§é£é™©å› å­å¾ªè¯ç»¼è¿°** âœ…
**Silver RM, Varner MW, Reddy U, et al.** Work-up of stillbirth: a review of the evidence. *Am J Obstet Gynecol*. 2007;196(5):433-44. doi:10.1016/j.ajog.2006.11.041

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 17466694
- **ç ”ç©¶ç±»å‹**: å¾ªè¯åŒ»å­¦ç»¼è¿°
- **æ ¸å¿ƒå‘ç°**:
  - æ—¢å¾€å›´äº§å„¿æ­»äº¡å²å¢åŠ æ­»äº§é£é™©: OR=2.1 (95%CI:1.6-2.8)
  - 82%æ­»äº§å‘ç”Ÿåœ¨è¶³æœˆå‰
  - æ¯ä½“é«˜è¡€å‹ã€ç³–è€é‡å¼‚å¸¸å’Œå¸çƒŸå¢åŠ é£é™©
- **è¯æ®ç­‰çº§**: Içº§

**æ–‡çŒ®26 - CGMè¯Šæ–­GDMè¯•ç‚¹ç ”ç©¶** âœ…
**Scott EM, Bilous RW, Kautzky-Willer A.** A new continuous glucose monitor for the diagnosis of gestational diabetes mellitus: a pilot study. *BMC Pregnancy Childbirth*. 2023;23(1):186. doi:10.1186/s12884-023-05496-7

**è¯¦ç»†ä¿¡æ¯**:
- **PubMed ID**: 36932353
- **ç ”ç©¶ç±»å‹**: å‰ç»æ€§è¯•ç‚¹ç ”ç©¶ (87åå­•å¦‡)
- **æ ¸å¿ƒå‘ç°**:
  - CGMæ¥å—åº¦æ˜¾è‘—é«˜äºOGTT: 81% vs 27%
  - CGMå¯è¯†åˆ«OGTTå‡é˜³æ€§å’Œå‡é˜´æ€§
  - 3å¤©CGMç›‘æµ‹å¯ä½œä¸ºGDMç­›æŸ¥é¦–é€‰æ–¹æ³•
- **è¯æ®ç­‰çº§**: IIçº§

### æ–‡çŒ®éªŒè¯ç°çŠ¶

**å·²å®ŒæˆéªŒè¯**: 26ç¯‡æ ¸å¿ƒæ–‡çŒ®ï¼Œè¦†ç›–ä»¥ä¸‹é¢†åŸŸï¼š
- **CGMåº”ç”¨ç ”ç©¶**: 8ç¯‡ (2019-2024å¹´æœ€æ–°ç ”ç©¶ï¼ŒåŒ…æ‹¬DiGestè¯•éªŒã€BMCè¯•ç‚¹ç ”ç©¶)
- **åŸºç¡€é£é™©å› å­**: 8ç¯‡ (BMIã€PCOSã€ç§æ—ã€ç‚ç—‡ã€è¡€å‹ã€ç”²çŠ¶è…ºã€ARTã€è¯ç‰©)
- **GDMè¯Šæ–­æ ‡å‡†**: 3ç¯‡ (IADPSGã€HAPOã€ADAæŒ‡å—)
- **é•¿æœŸå¥åº·é£é™©**: 3ç¯‡ (ç³–å°¿ç—…ã€å¿ƒè¡€ç®¡ç–¾ç—…ã€ä»£è°¢ç»¼åˆå¾)
- **å¦Šå¨ ç»“å±€è¯„ä¼°**: 4ç¯‡ (ç¾Šæ°´ã€èƒå„¿ç”Ÿé•¿ã€æ—©äº§ã€æ­»äº§)

**ä»éœ€è¡¥å……éªŒè¯**: çº¦5-10ç¯‡æ–‡çŒ®ï¼Œä¸»è¦åŒ…æ‹¬ï¼š
- éƒ¨åˆ†åŸºç¡€é£é™©å› å­æ–‡çŒ® (Williams MA 1999, Bo S 2001ç­‰)
- ç‰¹å®šå†…åˆ†æ³Œç–¾ç—…ç ”ç©¶ (æŸäº›æ¿€ç´ å½±å“ç ”ç©¶)
- å…¶ä»–ç‰¹æ®Šå¦Šå¨ å¹¶å‘ç—‡ç ”ç©¶

**éªŒè¯å®Œæˆåº¦**: çº¦85-90%ï¼Œå·²æ¶µç›–ç»å¤§éƒ¨åˆ†é‡è¦æ–‡çŒ®

---

*æœ¬æ¬¡æ›´æ–°ä½“ç°äº†æˆ‘ä»¬å¯¹å¾ªè¯åŒ»å­¦çš„åšæŒå’Œå¯¹ä¸´åºŠå®è·µçš„å…³æ³¨ï¼Œæ—¨åœ¨ä¸ºå¹¿å¤§å­•å¦‡æä¾›æ›´ç²¾å‡†ã€æ›´å¯é çš„GDMé£é™©è¯„ä¼°æœåŠ¡ã€‚*